• FURTHER INCREASE IN SALES AND EARNINGS.
  • STRONG GROWTH RATES IN ORDER INTAKE AND ORDER BACKLOG. 
  • WELL POSITIONED FOR FURTHER GROWTH. 
  • Print page
  • Save as PDF
  • Add to Cart
  • Recommend Page
Home arrow Fresenius Group arrow Business Segments arrow Fresenius Vamed

Print

Fresenius Vamed 

Fresenius Vamed had a successful year in 2007 – with sales growth of 4% and EBIT growth of 13%. Order intake and order backlog also developed strongly. This is a good basis for further growth.

Fresenius VAMED specializes in international projects for hospitals and other health care facilities. In 2007, the company celebrated its 25th anniversary. Founded in 1982, VAMED has grown from a small project company to become one of the world’s leading providers of a full line of services for the health care industry. VAMED was originally established to construct the Vienna General Hospital and University Clinic (AKH) and equip it for operation. To assure the proper functioning of the technical installations, VAMED was also commissioned with the technical management of AKH in 1986. We still perform this function today. Meanwhile, we are well positioned with a comprehensive portfolio of services. We have completed approximately 450 projects in 47 countries. Our portfolio ranges from project development, planning and turnkey construction, via facility management, through to the total operational management of hospitals and other health care facilities. VAMED is also a pioneer in public-private partnership (PPP) models for hospitals in Central Europe.

Fresenius Vamed has the following structure:

Fresenius Vamed Structure

BUSINESS DEVELOPMENT

In 2007, Fresenius Vamed increased sales by 4% to € 408 million (2006: € 392 million).

The table shows the sales development by activity:

in million €
2007 2006 Change
 
Project business 259 249 4%
Service business 149 143 4%
 

Sales in the project business and in the service business increased by 4% each. Sales in the project business rose to € 259 million and sales in the service business to € 149 million. 

In 2007, Fresenius Vamed’s strongest sales regions were Europe (59%) and Africa (31%), followed by Asia-Pacific and Latin America (9% and 1%, respectively).

Sales BY rEGION
Sales By Region